Equity Overview
Price & Market Data
Price: $1.60
Daily Change: -$0.01 / 0.63%
Daily Range: $1.56 - $1.66
Market Cap: $75,360,312
Daily Volume: 280,889
Performance Metrics
1 Week: -10.86%
1 Month: -11.86%
3 Months: -23.15%
6 Months: -60.10%
1 Year: -0.64%
YTD: -21.21%
Company Details
Employees: 20
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Filana Therapeutics, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is in Phase 3 clinical trial to treat Alzheimer's disease; and investigational diagnostic product candidate is SavaDx, an early-stage program focused on detecting the presence of Alzheimer's disease from a small sample of blood. The company was formerly known as Cassava Sciences, Inc. and changed its name to Filana Therapeutics, Inc. in March 2026. The company was incorporated in 1998 and is based in Austin, Texas.